Moirai Biodesign (Seed)
Funding Details
Date Award
May 13, 2024
Vertical
Biotech
Funding URL
View Funding Page
Company Info
Founding Year
2019
Traction
Moirai Biodesign has successfully validated its platform through preclinical studies and is preparing for clinical trials. The company has established partnerships with leading research institutions and pharmaceutical companies to advance its pipeline of novel therapeutics.
Organizations Involved
SOSV, XYZ Ventures, Stanford University, Genentech
Founders
Alice Chen, David Lee
Market
Healthcare
Location
San Francisco, CA, US
Coinvestors
SOSV, XYZ Ventures
Company Description

Moirai Biodesign is a biotech company specializing in developing novel therapeutics for autoimmune diseases. Their proprietary platform leverages advanced computational biology and machine learning algorithms to identify potential drug targets and design customized treatments. By focusing on autoimmune disorders, Moirai Biodesign aims to address unmet medical needs and improve patient outcomes through personalized medicine.

Links
Website
Back to HomeBack to Biotech DealsView Funding Announcement